Probing hypoxia-induced staurosporine resistance in prostate cancer cells with a microfluidic culture system
Authors:
- 20 January 2014
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 139 (13) , 3274-3280
Abstract
A microfluidic system for cell culture and drug response studies was developed to elucidate the effects of hypoxia on drug susceptibility. Drug response studies were performed in prostate cancer cells and Ramos B cells under normoxic and hypoxic conditions. A vacuum actuated microfluidic culture device was used for cell culture and PC3 cells were cultured in the chip up to 16 hours. Cells were treated with several concentrations of staurosporine and apoptosis was assayed using the fluorescent probes MitoTracker Deep Red and Annexin-V. For hypoxic samples, the chip was placed in a hypoxia chamber and pre-conditioned at <1% oxygen before inducing the cells with staurosporine. Cells exposed to 2 μM staurosporine were 32% ± 10% apoptotic under normoxic conditions but only 1.5% ± 12% apoptotic under hypoxic conditions. As little as 1 hour of hypoxic preconditioning increased drug resistance. Cell apoptosis correlated with drug dose, although in each case hypoxia reduced the apoptotic fraction significantly. Given the rapid nature of cell adaptation to hypoxia, this chip and analysis approach can be used to identify compounds that can induce cell death in hypoxic tumor cells rapidly.Keywords
This publication has 30 references indexed in Scilit:
- Generation of a chemical gradient across an array of 256 cell cultures in a single chipThe Analyst, 2013
- Islet Preconditioning via Multimodal Microfluidic Modulation of Intermittent HypoxiaAnalytical Chemistry, 2012
- High-resolution dose–response screening using droplet-based microfluidicsProceedings of the National Academy of Sciences, 2011
- Regulating Oxygen Levels in a Microfluidic DeviceAnalytical Chemistry, 2011
- Apoptosis goes on a chip: advances in the microfluidic analysis of programmed cell deathAnalytical Chemistry, 2011
- Ischemia/reperfusion injury of primary porcine cardiomyocytes in a low-shear microfluidic culture and analysis deviceThe Analyst, 2011
- Tumors on chips: oncology meets microfluidicsCurrent Opinion in Chemical Biology, 2010
- Assay of glioma cell responses to an anticancer drug in a cell-based microfluidic deviceMicrofluidics and Nanofluidics, 2010
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Hypoxia as a target for combined modality treatmentsEuropean Journal of Cancer, 2002